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The induction of ornithine decarboxylase levels by the 
phorbol ester 12-0-tetradecanoyl-phorbol-13-acetate 
(TPA) in mouse skin has been shown to be integral to 
tumor promotion by TP A, and changes in ornithine 
decarboxylase activity indicate the proliferative state 
of many different cell types. However, in cultured 
human epidermal cells, TPA has been reported to be 
anti proliferative. Therefore, to elucidate pathways 
that TP A activates in cultured human skin cells, we 
have examined the levels at which TP A regulates orni-
thine decarboxylase gene expression in two immortal-
ized human epidermal keratinocyte cell lines, and in 
normal neonatal keratinocytes. We have found that in 
cultured human keratinocytes, TPA causes a marked 
decrease in ornithine decarboxylase enzyme activity 
(50-90%), with no detectable effect on ornithine de-
T he phorbol ester 12-0-tetradecanoy l-phorbol-13-ac~­tate (TPA) is a potent tumor promoter m mouse skm [1], where it induces ornithine decarboxylase (ODC, E.C.4.1.1.17) [2.3]. a recently identified proto-onco-gene [4]. ODC is the rate-limiting enzyme in polya-
mine biosynthesis. and its activity correlates with the cellular 
growth state. TPA increases ODC enzyme levels 200-400-fold i.n 
mouse skin [5]. and ODC mRNA levels ten- to twentyfold [6]. TIllS 
increase in ODC activity, and hence polyamine levels. appears nec-
essary for tumor promotion, as abrogation of the rise in ODC by 
pretreatment with all-trans-retinoic acid [7]. or with the ODC irre-
.Iersible inhibitor a-difluoromethylornithine (a-DFMO) [8], abol-
fis hes papilloma formation. 
Phorbol esters cause epidermal hyperplasia in humans and one 
group finds increases in ODC activity in human skin explants [9]. 
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carboxylase mRNA levels. TP A decreased steady-state 
levels of ornithine decarboxylase immunoreactive 
protein (-50-67%), accounting for the 50-90% sup-
pression of ornithine decarboxylase activity levels, as 
well as decreasing new synthesis of ornithine decar-
boxylase protein (48-50%). However, measurement 
of ornithine decarboxylase protein half-life showed no 
significant effect of' TP A. Also, prolonged treatment 
ofkeratinocytes with phorbol esters abolished the sup-
pression of ornithine decarboxylase activity by TP A. 
Our data, therefore, suggest that phorbol esters sup-
press ornithine decarboxylase gene expression pre-
dominantly by decreasing ornithine decarboxylase 
mRNA translatability. Key word: TPA. ] Invest Dermatol 
103:687-692,1994 
However. in adult human skin cultures. TPA caused decreased 
DNA synthesis and either no change [10] or decreased ODC activ-
ity [11]. suggesting that, in humans, TPA is anti-proliferative. As 
mouse-skin tumor formation strongly correlates with increased 
ODC gene expression, we examined the mechanism of regulation 
by TPA on ODC gene expression in immortalized and normal 
neonatal human epidermal keratinocytes (NHEK). In contrast to 
cultured rodent cells [5,6], TPA causes decreased ODC enzyme 
activity, suppresses levels of newly synthesized immunoreactive 
ODC protein, but has no effect on ODC mRNA levels. A small but 
not statistically significant decrease in ODe half-life was measured 
after TP A treatment. Prolonged pre-treatment of the cells with 
phorbol esters abolishes ODC suppression by TPA, consistent with 
a saturable pathway such as the protein kinase e (PKC) pathway. 
Phorbol esters therefore suppress ODC gene expression in human 
keratinocytes, and the data imply that this effect occurs predomi-
nantly through decreased ODC mRNA translatability. 
MATERIALS AND METHODS 
Materials [a-32P]dCTP, [a-32P]dGTP (3000 Ci/mmol), L-[35S]methio-
nine (> 1100 Ci/mmol), L-[lI4C]ornithine (40-60 mCi/mmol), and 
['H]thyrnidine (77.2 Ci/mmol) were from DuPont-NEN. TPA, PDBu, 
4a-PDD, trypan blue, newborn bovine serum, and cell-culture-grade L-
methionine were from Sigma. Polyclonal antiserum to mouse ODC [12] 
was kindly supplied by Dr. O. A. Janne (University of Helsinki, Finland); 
rabbit antibody to chicken actin was from ICN Biomedicals, Inc. 
Cell Culture RHEK-l cells were established from primary human fore-
skin epithelial cells following infection with Ad12-SV40 virus [13]. HPK-
0022-202X/94/S07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. 
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1A cells resulted from transfection of primary human epidermal cells with 
human papilloma virus 16 [14]. Both nontumorigenic, immortalized kerati-
nocyte cel l lines, RHEK-1 and HPK-IA, were cultured as described [13]. All 
experiments were conducted in -75% confluent cultures in Dulbecco's 
modified Eagle's medium (DMEM) containing 10% charcoal-treated [15] 
newborn bovine serum (to remove retinoids and steroid hormones [15] 
known to regulate ODC activity [16]). NHEK, obtained from neonatal 
foreskins, were maintained in keratinocyte growth medium (KGM, Clone-
tics) supplemented with 50,ug/ml bovine pituitary extract. 
TPA and 4a-PDD were dissolved in ethanol; PDBu was dissolved in 
Me2S0. Control cultures were treated with vehicle alone at concentrations 
not exceeding 0.1 % (v Iv). All treatments were initiated by addition of fresh 
culture medium containing the test agent. 
Northern Blot Analysis of ODC mRNA Total RNA was isolated 
using the guanidinium isothiocyanate/CsCI method [17], and 15-20,ug of 
total RNA were fractionated on a 1 % agarose/2.2 M formaldehyde gel, 
transferred to Nitro Plus membranes (Micron Separations, Inc.), and hybrid-
ized [18] with a nick-translated EcoRl fragment of the human ODC eDNA 
[19] and a rat cyclophilin eDNA [20]. Labeled bands were visualized by 
exposure of the blots to Kodak XAR-2 X-ray fi lm at -70· C with an inten-
sifying screen, and quantitated with a Hoeffer Transmittance/Reflectance 
Scanner. 
ODC Activity Cells were lysed by three freeze/thaw cycles in 25 mM 
Tris-HCI, 0.1 mM ethylenediaminetetraacetic ac id, S mM dithiothreitol, 
pH 7.4, cytosols isolated by centrifugation at 150,000 X g for 30 min, 4· C, 
and ODC activity was measured by the 14C02-release assay [21] 
(Cr.omhh;ne = 0.5 mM). Background 14C02 release was determined using cy-
tosol incubated with the ODC inhibitora-DFMO (5 mM) (gift of Dr. P. P. 
McCann, Merrell Dow Research Institute, Cincinnati, OH). Protein con-
centrations were determined using the Bio-Rad protein assay kit. The sig-
nificance of differences in the means as compared to control levels was 
determined using the Student t test for unpaired data. 
Metabolic Labeling and Immunoprecipitation of ODC Protein 
Approximately 70% confluent cells were incubated in methionine-free 
DMEM containing either 100 ng/ml TPA or vehicle for 6 h. For steady-
state and half-life determinations, 1 ,uCi/ml [355] methionine was included 
during the 6 h treatment; for new synthesis, 1 ,uCi/ml [3SS] methionine was 
added 15 min prior to harvesting. In half-life experiments, the chase was 
initiated by adding a 500-fold excess of unlabeled methionine. Cells were 
trypsinized and suspended in 550,ul of 150 mM NaCI, 5 mM ethylenedia-
minetetraacetic acid, 50 mM Tris-HC1, 0.5% Nonidet P-40, 0.1 % sodium 
dodecylsulfate, pH 7.4 (buffer A), and lysed by three freeze/thaw cycles. 
Total [355) methionine-labeled, cellular protein was precipitated with tri-
chloroacetic acid; total incorporated counts for treated cultures were not 
statistically different from untreated cultures. An equal number of counts 
were used for immunoprecipitation. by incubation with 3 ,Ill of ODC anti-
serum, 3,ul of anti-actin antiserum [12], or both antisera, for 18 h, 4"C, 
followed by incubation with StaphylococCIIs aurws cells (Pansorbin, Calbio-
chern) for 45 min at room temperature. Absorbed complexes were pelleted 
at 13,000 Xg, for 10 min, 25"C, and washed three times with buffer A 
containing 0.5% Na-deoxycholate. Samples were boiled in 66 mM Tris-
HC1, 30% glycerol [v : v], 15% p-mercaptoethanol [v: v), 7% sodium dode-
cylsulfate [w: v], 0.003% bromophenol blue [w: v], pH 6.8, for 3 min, and 
were analyzed on a 10% sodium dodecylsulfate-polyacrylamide gel [22]. 
Labeled proteins were visualized by fluorography using Enhance (DuPont-
NEN) and quantitated by densitometry. 
(3H)Thymidine Incorporation Approximately 3000 cells per well of a 
96-well plate were grown to - 60% confluence, and treated with 100 ng/ml 
TPA or ethanol for 6, 24, or 48 h with fresh addition of agent in medium 
every 24 h. Cells were trypsinized, an aliquot used to determine cell num-
bers, and the remainder washed four times with cold phosphate buffered 
saline (PBS), re-suspended in PBS, lysed by three freeze/thaw cycles, and 
applied to GF /C filters (Whatman International Ltd., Maidstone, England). 
Fi lters were washed six times for 2 min, with cold 5% trichloroacetic acid, 
20 mM sodium phosphate, rinsed with 70% ethanol for 2 min, 2S"C, and 
dried. Incorporated counts were measured by counting in a beta counter 
using Ecolume (ICN Biochemicals, Inc., Costa Mesa, CAl. 
RESULTS 
TPA is a potent tumor promoter in mouse skin; however, in human 
skin culture it appears to be anti-proliferative [10]. In murine epi-
dermis, TPA increases immunoreactive ODC amounts, increases 
cell number, and increases heterogeneity in cell size and granulosity 
[23]. However, a subset of rodent epidermal cells responds to TPA 
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Figure 1. Concentration dependence of the effect of TP A on ODC 
activity in RHEK-l, HPK-IA, and NHEK cells. RHEK-1 (a) or HPK-
lA (b) cells were treated with 0.1-100 ng/ml TPA or vehicle alone (0 ng/ 
ml) for 6 hand ODC activity determined and expressed as percent of control 
levels. Each poillt represents the mean ± SD of at least three experiments with 
three independent determinations per dose per experiment. Control ODC 
activity is 6 - 11 or 1.0 - 1.8 nmoles CO2/h/mg protein for RHEK-l and 
HPK-1A cells, respectively. RHEK-l cells were less sensitive to TPA than 
HPK-IA cells [ICso.RH1.!K - 5 ng/ml; ICso.HPK_IA - 0.5 ng/ml] . c: NHEK 
were cultured from neonatal foreskins and seeded into two 60-mm2 plates at 
passage 1. One plate was treated with 100 ng/ml TPA and the other with 
vehicle for 6 hand ODC activity determined. TPA treatment caused a 
40 - 90% decrease in ODC activity as compared to control levels. Each point 
represents a single determination of ODC activity from control and treated 
cells from an individual foreskin . Significance, as compared with control 
cultures using the student's unpaired t test: "0.0002 < P < 0.0007; 
'0.01 < P < 0.05. 
along an anti-proliferative pathway [24 - 26]. In cultured human 
epidermal cells, TPA decreases DNA synthesis with either no 
change [10] or a decrease [11] in ODC activity. We therefore asked 
at what level{s) TPA regulated ODC gene expression in cultured 
human skin cells. 
We first determined the effect ofTPAonODCactivity. RHEK-
1 [13] and HPK-1A [14] keratinocytes were treated with 0.1-
100 ng/ml TPA for 6 h, the time of maximal effect in rodent skin 
[2,3,6]. Both cell lines exhibited a concentration-dependent 
decrease in ODC activity (Fig 1), with ODC activity in 
HPK-IA cells tenfold more responsive to TPA than RHEK-l cells 
(ICso. !iPK-I'" - 0.5 ng/ml; ICso. R!iEK-1 - 5 ng/ml TPA). Cel l via-
bility, as measured by trypan blue exclusion, showed no TPA-asso-
ciated cell death over 24 h. Furthermore, addition of fresh medium 
increased ODC activity at 3 - 6 h, indicating a normal response to a 
growth stimulus. 
The effect of TPA on ODC activity was then determined in 
normal keratinocytes. NHEK from individual neonatal foreskins, 
which to minimize effects of tissue culture were used at pl, were 
treated with 100 ng/ml TPA, or with vehicle, for 6 h, and ODC 
activity was determined from one plate of each. TPA suppressed 
ODC activity by 40-90% (Fig 1e). 
We then delineated the effects ofTPA with time on ODC activ-
ity. Cells were treated with lOO ng/ ml TP A or vehicle for times up 
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Figure 2. The effect of100 ngjml TPA on ODe activity in RHEK-
1, HPK-1A, and NHEK cells at times up to 24 h. Cells were treated with 
100 ng/ml TPA (0) or vehicle alone (e) for up to 24 hand ODC activity 
was determined and expressed as nmoles COih/mg protein. In HPK-IA 
and NHEK cells, TPA caused maximal suppression of ODC activity at 
3 -6 h; in RHEK-l cells, at 6 h. By 24 h, ODC activity had returned to 
control levels in the immortalized cell lines; NHEK showed a further sup-
pression of ODC activity by TPA. Each poi"t represents the mean ± so 
from a single experiment with three independent plates and one (RHEK-l 
and HPK-IA) or two (NHEK) determinations of ODC activity/plate. Each 
experiment was repeated three times and gave qualitatively similar results. 
Significance: as compared with control cultures using the Student unpaired t 
test. "0.0002 < P < 0.0008; '0.005 < P < 0.010. 
to 24 h, and ODC activity showed maximal suppression at3-6 h in 
HPK-IA and NHEK cells, and at 6 h in RHEK-l cells (Fig 2). In 
both immortalized lines, ODC activity returned to control levels by 
24 h, whereas in NHEK ODC activity continued to be suppressed 
at 24 h. 
To test the effect ofTPA on keratinocyte proliferation, the effect 
of 100 ng/ml TPA on DNA synthesis was measured at 6, 24, and 
48 h in HPK-IA, RHEK-l , and NHEK. Fresh medium containing 
agent was added every 24 h, and 100 flCi/ml of [3H]thymidine in 
fresh medium was added 6 h prior to harvesting, cell number deter-
mined by cell countin g, and [3H]thymidine incorporation deter-
mined by precipitation with 10% trichloroacetic acid (Fig 3). In 
RHEK-l and in HPK-IA cells, TPA did not significantly suppress 
DNA synthesis at up to 48 h. However, in NHEK, 48 h ofTPA 
treatment significantly decreased DNA synthesis (19% of 48 h con-
trollevels, whose rise in DNA synthesis reflects the growth stimu-
lus of repeated medium changes). Therefore, the transient decrease 
in ODC levels in RHEK-l and HPK-IA cells reflected the effects of 
TPA on DNA synthetic rates, i.e., no lasting change. However, in 
NHEK, the ODC activity was decreased at 24 h ofTPA treatment, 
and this was reflected in decreased DNA synthetic rates at 48 h of 
TPA treatment, although no significant change in cell number 
(3.4 X 105 ± 1.0 X 105 or 2.8 X 105 ± 0.88 X 105 cells for control 
or TPA treated, respectively) was measured. 
We next asked if TPA decreased levels of the mRNA encoding 
ODe. RHEK-l or HPK-IA cells were treated with 0.1-100 ng/ 
ml TPA or vehicle alone for 6 h, total RNA was isolated, and ODC 
mRNA levels determined by hybridization of a northern blot to 
human ODC cDNA [19] (Fig 4). Variations in RNA amounts were 
corrected for by hybridization with rat cyclophilin cDNA [20) . No 
significant changes were observed in ODC mRNA levels at any 
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Figure 3. Effect of time ofTPA treatment on 3H-thymidine uptake 
in RHEK-1, HPK-1A, and NHEK cells. Cells were treated with 100 ng/ 
ml TPA (e) or vehicle alone (0) for 6, 24, or 48 h, with fresh medium 
containing agent added every 24 h. Six hours prior to harvesting, 100 /.lCi/ 
ml [3H]thymidine in fresh medium was added. Incorporation of[3H]thymi-
dine was determined by binding of cell lysate to glass fiber filters after six 5% 
trichloroacetic acid, 20 mM sodium phosphate washes. Incorporation is rep-
resented as percent control of cpm incorporated in control cells not exposed 
to ethanol or TPA at t = O. Only NHEK cells showed a significant suppres-
sion of DNA synthetic rates after TPA treatment. Each poillt is the average of 
two independent experiments with each experiment containing four indi-
vidual wells of cells whose [3H]thymidine uptake was determined indepen-
dently. Significance, as compared with control cultures using the Student 
unpaired t test: " p < 0.005. 
TPA dose. Similarly, in NHEK treated for 6 h with 100 ng/ml 
TPA or vehicle alone, no changes in ODC mRNA levels were 
observed (Fig 4). ODC mRNA levels in RHEK-l and HPK-IA 
cells that were treated with 100 ng/ml TPA or with vehicle alone 
for 0.5 - 24 h showed no significant changes at any time (data not 
shown). Thus, there was no measurable effect of TPA on ODC 
mRNA levels. 
To determine if decreased ODC activity was paralleled by de-
creased ODC protein levels, the effect ofTPA on immunoreactive 
ODC protein was measured. New synthesis of ODC protein was 
measured in cells treated for 6 h with 100 ng/ ml TP A or vehicle in 
methionine-free medium, and labeled for 15 min prior to harvest-
ing with 1 flCifml [35S]methionine. Steady-state levels of ODC 
protein w ere measured in cell s treated with 100 ngj ml TPA or 
vehicle for 6 h in methionine-free medium containing 1 flCi/ml 
[35S)methionine. In each experiment, incorporated counts from 
treated and control cultures were not significantly different and 
equal numbers of counts of radio labeled protein were used for im-
munoprecipitation with rabbit anti-mouse ODC antibody [12); p-
actin was immunoprecipitated at the same time with rabbit anti-
chicken actin antibody. Immunoprecipitated proteins were 
fractionated by sodium dodecylsulfate- polyacrylamide gel electro-
phoresis. TP A treatment caused a decrease in steady-state and in 
newly synthesized, immunoprecipitable ODC protein (Fig 5); the 
decrease in ODC protein levels in HPK-IA cells was similar under 
both conditions (50% for steady state, 48% for new synthesis), 
whereas steady-state levels of 0 DC protein in NHEK decreased to a 
greater extent than newly synthesized ODC protein (67% for 
steady state, 50% for new synthesis), suggesting a small role for 
protein stability. Therefore, we determined the effect of TPA on 
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Figure 4. Concentration dependence of the effect ofTPAon ODC 
mRNA levels. Approximately 75% confluent RHEK-1, HPK-IA, or nor-
mal human epidermal keratinocytes (NHEK) were treated with TPA (or 
vehicle = 0 ng/ml) in fresh medium for 6 h. Total RNA was isolated and 
ODC and cyclophilin mRNA levels determined by Northern blot hybrid-
ization of 15 Ilg of total RNA with the 32P-labeled human ODC cDNA or 
rat cyclophilin cDNA (a). Each dose response was performed three times 
with no measurable change in ODC mRNA levels relative to cyclophilin 
mRNA levels at any dose, as determined by densitometry (b) . 
ODC degradation. Cells were incubated with 100 ng/ml TPA for 
6 h in methionine-free medium containing 1 ,uCi/ml [35S]methio-
nine. From 15 min to 2 h after addition of a SOO-fold excess of cold 
methionine, ODe and p -actin protein were immunoprecipitated 
from cell cytosols containing equal numbers of counts, and frac-
tionated by sodium dodecylsulfate - polyacrylamide gel electropho-
resis. The half-life of ODC decreased slightly in TPA-treated 
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Figure 5. The effect ofTPAon synthesis of ODC protein. HPK-1A or 
NHEK were treated with 100 ng/ml TPA or vehicle alone for 6 h in methi-
onine-free DMEM; 15 min prior to harvesting, 1 j.lCi/ml of [35SJmethio-
nine was added to the medium (labeling time 15 min) or cells were incubated 
with 11lCi/ml of [3sSJmethionine throughout the treatment period (label-
ing time 6 h). Metabolically labeled ODC and p-actin was immunoprecipi-
tated using their respective antibodies from cytosols that contained equal 
numbers of counts and approximately equal protein amounts (protein 
immunoprecipitated, HPK-1A, OISmln = 0.764 mg; 100lSmin = 0.760 mg 
06h = 1.047mg, 1006h = 1.334 mg; NHEK, 0ISnun = 2.892 mg; 
10015 min = 2.678 mg; 06h = 0.484 mg; 1006h = 0.514 mg). Immuno-
precipitated protein were fractionated by sodium dodecylsulfate - poly-
acrylamide gel electrophoresis and relative amounts of immunoprecipitated 
ODC was determined by densitometry. For HPK-1A, TPA treatment 
caused a 48% (15 min) or 50% (6 h) decrease in ODC protein levels. For 
NHEK, TPA treatment caused a 50% (15 min) or 67% (6 h) decrease in 
ODC protein levels. Each experiment was performed a minimum of three 
times and gave qualitatively similar results. 
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Figure 6. Effect ofTPA on ODC protein half-life in normal human 
epidermal keratinocytes. Approximately 75% confluent NHEK in 60-
mm2 tissue culture dishes were incubated with 100 ng/ml TPA or vehicle 
alone for 6 h in keratinocyte growth medium containing 1llCi/ml [,5SJme-
thionine. At t = 0, a SOO-fold excess of cold methionine was added to the 
plates and cells were harvested at the times indicated (a). ODC and p-actin 
(in the top two panels) were immunoprecipitated using their respective 
antibodies from cytosols containing equal numbers of counts and fraction-
ated on 10% sodium dodecylsulfate-polyacrylamide gels. Radiolabeled 
protein was determined by f1uorography and relative levels of immunopre-
cipitated protein were determined by LASER-scanning densitometry. Tluee 
different half-life determinations are shown. b: densitometry values for the 
above autoradiograms were used to determine ODC half-life in TPA-treated 
(7) and untreated (0) NHEK, and expressed as log (percent control); where 
the control value was the t = 0 value for the indicated treatment. Linear 
regression yielded a tl/2 = 85.8 min for ODC in control NHEKculturesand 
81.0 min for TPA-treated NHEK. However, 0.2 < P < 0.5 for a difference 
between the two slopes, suggesting that the changes in tl/2 are not signifi-
cant. 
NHEK cells (t1(2 = 81.0 and 85.8 min for treated and untreated 
cells, respective y, 0.2 < P < 0.5, Fig 6) . In addition, the t1/2 for 
ODC in RHEK-l and in HPK-1A cells was estimated to be greater 
than 2 h . The data therefore suggest that changes in tl/2 do not 
appreciably contribute to the regulation of ODC by TPA. 
As TP A is able to activate PKC, we examined the effect of phor-
bol 12,13-dibutyrate (PDBu) and 4a-phorbol 12,13-didecanoate 
(4a-PDD), phorbol esters that activate and are unable to activate 
PKC, respectively [27] , on ODC gene expression. RHEK-l were 
treated with 100 ng/ml 4a-PDD or vehicle alone for 6 h, and 
ODC activity was determined (Fig 7A) , with 4a-PDD showing no 
significant effect on ODC activity. The active phorbol ester PDBu 
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Figure 7. The effect of different phorbol esters on ODe activity. A: 
RHEK-l cells were treated with 100 ng/mI4a-PDD, an inactive phorbol 
ester, or with vehicle alone for 6 h. No significant changes in ODe activity 
were measured. e = 16.05 ± 3.3, 4a-PDD = 16.52 ± 2.3 nmoles CO,) 
h/mg protein. B: HPK-IA cells were treated with 100 ng/ml PDBu or 
vehicle alone (C) for 6 h and ODe activity measured. PDBu caused an 
-60% decrease in ODe activity. e = 7.6-13.3 nmoles eOz/h/mg pro-
tein. c: HPK-IA cells were treated with 100 ng/ml PDBu for 24 h. Fresh 
medium was added containing either 100 ng/ml TPA (TPA) or vehicle 
alone (C) and ODe activity determined after incubation for 6 h. Additionof 
TPA caused no suppression of ODe activity (e = 3.16 ± 0.75 nmoles 
eOz/h/mg protein). All panels represent averages of at least two experi-
ments and each experiment had three parallel determinations from sets of 
parallel plates. Significance, as compared with control cultures, using the 
Srudent t test for unpaired values: "0.001 < P < 0.005. 
(100 ng/ml, 6 h) also reduced ODe activity in HPK- IA cells to the 
same extent as TPA (Fig 7B). 
Activation of pathways involving PKe can be abolished by pro-
longed treatment with phorbol esters [28]. Therefore, ifpDBu and 
TP A act via such a pathway, pretreatment with PDBu should render 
ODe activity insensitive to a subsequent challenge with TPA. 
HPK-IA cells were incubated with 100 ng/ml PDBu for 24 h, 
followed by 100 ng/ml TPA or vehicle alone for 6 h. After 24 h 
incubation with PDBu, ODe activity in treated cells was indistin-
guishable from that measured in untreated, control cells (3.16 ± 
0.75 nmoles e02/h/mg protein versus 4.28 ± 1.05 nmoles e02/ 
h/mg protein, respectively). ODe activity in cultures that were 
then treated with TPA was not significantly different from that in 
cultures that had received vehicle alone (Fig 7C). Together these 
data suggest that PDBu and TPA, phorbol esters that can activate 
PKe, act via a pathway that can be saturated to regulate ODe 
activity. 4a-PDD, which is unable to activate protein kinase e, also 
does not regulate ODe levels. 
DISCUSSION 
ODe is the first and apparently rate-limiting enzyme in the biosyn-
thesis of polyamines, and recent studies have implicated ODe as a 
proto-oncogene [4]. ODe levels are regulated transcriptionally 
116,29], translationally [30], and by protein stability [31], which is 
unusually short (tl/2 = 57 min in cultured hamster fibroblasts [5]). 
In mouse epidermis, TPA is both proliferative [2,3] and anti-pro-
liferative [24-26] with active hair growth linked to tumor forma-
tion [32]. TPA has been reported to cause small increases in ODe in 
adult human skin explants, suggesting a proliferative role for TPA 
[9]. However, in human skin cell cultures, TPA appears to be pre-
dominantly anti-proliferative [10,11]. Whether the differences ob-
served in these human skin models are due to methodology, the 
biopsy site, donor age, or the subpopulation of keratinocytes that 
grow in tissue culture, has yet to be explored. 
In view of the marked contrast between the effects of TP A in the 
human and murine cell culture systems, we have delineated the 
level of control ofTPAonODegeneexpressioninboth immortal-
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ized human cells and NHEK, as a first step towards understanding 
the differences between the murine and the human systems. 
Our initial experiments on ODe activity indicated that treat-
ment with TPA suppressed ODe enzyme activity in RHEK-l, in 
HPK-IA, and in NHEK. Interestingly, HPK-IA cells were approx-
imately tenfold more sensitive to TPA treatment than RHEK-l 
cells. As both lines are derived from neonatal foreskins, this differ-
ential sensitivity may indicate altered cellular responses due to the 
different viral transformations. One hundred nanograms per milli-
liter TPA suppressed NHEK ODe levels to 10 - 60% of control 
levels, showing that the immortalized lines responded to TP A in 
the same direction as NHEK. 
We then determined if DNA synthetic rates were also suppressed 
after TP A treatment. No decrease in DNA synthetic rates and only a 
transient decrease in ODe activity at 3 - 6 h ofTPA treatment were 
measured in RHEK-l and HPK-1A cells. Presumably, these results 
reflect the immortalized state of these cells. In NHEK, however, 
TPA caused suppression of ODe levels from 3 h ofTPA treatment 
and caused a significant suppression of DNA synthetic rates by 48 h 
of TPA treatment. Although cell numbers were not significantly 
different from control levels, this decreased DNA synthesis could 
predict that cell growth would be suppressed at longer times. 
Therefore, TPA should be anti-proliferative in NHEK and the con-
tinued suppression of ODe correlates with the decrease in DNA 
synthetic rates. 
PKe is the major phorbol ester receptor and can be down-regu-
lated by prolonged activation [28]. Treatment with PDBu abolished 
the effect ofTPAon ODe activity levels, and the inactive phorbol 
ester 4a-PDD did not change ODe levels. Therefore, the ability to 
activate PKe correlated with the ability to suppress ODe activity 
levels, although clearly other pathways could also be involved. 
Both a time- and concentration-dependent decrease in ODe ac-
tivity was measured after TP A treatment, with a 50 - 90% decrease 
in ODe activity at 3-6 h. Interestingly, no change in ODe 
mRN A levels was measured at any concentration or time of TP A 
treatment. TPA caused, however, a 48-50% decrease in newly 
synthesized ODe protein levels, and a 50- 67% decrease in steady-
state levels. Therefore, the - 50% decrease seen in newly synthe-
sized ODe suggests an - 50% decrease in ODe mRNA translata-
bility. 
p -actin was inununoprecipitated with ODe by use of rabbit anti-
chicken actin antibody in these and in two of the half-life experi-
ments for use as an internal standard. However, it appeared that 
TPA significantly changed the levels of soluble actin, the form of 
actin present in the cytosolic fraction. TPA has been shown in other 
systems to affect the extent of actin polymerization [33J, and our 
data~ show that TPA profoundly alters the extent of actin polymer-
ization without altering total actin content, presumably due to al-
teration of the ratio of soluble to insoluble actin. Therefore, actin 
could not be used for normalization of ODe. However, TPA did 
not cause changes in total incorporated counts within an experi-
ment, and equal numbers of counts had been used for immunopre-
cipitation. Therefore, direct comparison of intensities of ODe 
bands was valid. 
After TPA treatment, small changes in the rate of ODe protein 
degradation rate were measured in either transformed cell line or in 
NHEK over the course of 2 h. However, the resulting half-lives 
only showed a 50 - 80% probability of being different and, there-
fore, we must conclude that changes in ODe protein half-lives are a 
minor component of the effect of TPA on ODe protein levels. 
ODe mRNA has been predicted to have extensive secondary 
structure in its 5' -noncoding region that severely inhibits its trans-
latability [34]; it IS therefore tempting to invoke regulation of the 
translatability of the human ODe mRNA as the mechanism of 
action ofTPA. However, TPA regulation of murine ODe biosyn-
'11 Promidor MM, Ruhl KK, Tuan RS, Hickok NJ: Relationship between 
ornithine decarboxylase and actin cytoskeleton organization in culrured 
human keratinocytes: cellular responses to phorbol esters, cytochalasin B, 
and a-difluoromethylomithine (submitted). 
692 RUHL ET AL 
thesis has been shown to be dependent on the ODe mRNA protein 
coding region [35], and ODe is selectively tagged for degradation 
by binding of its antizyme [36], suggesting protein stability as the 
mechanism. The experiments described in this report cannot distin-
guish between regulated translatability or selective degradation of 
newly synthesized protein. 
In conclusion, unlike in rodent skin cultures, TPA causes a large 
decrease in ODe activity in cultured human skin cells, and this 
regulation is solely due to mechanisms operating during and/or 
immediately after human ODe protein synthesis. In contrast, TPA 
causes stimulation of rodent ODe gene transcription, increased 
ODe mRNA levels, and increased ODe protein levels [2,6,35]. 
Thus, further elucidation of the mechanism by which TPA sup-
presses ODe biosynthesis in cultured human skin cells may begin to 
yield important insight into the molecular mechanisms governing 
the direction of the TP A response, and therefore the proliferative 
fate of the responding cell. 
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